Page last updated: 2024-09-03

3-(2,2,2-trimethylhydrazine)propionate and Liver Dysfunction

3-(2,2,2-trimethylhydrazine)propionate has been researched along with Liver Dysfunction in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Borković-Mitić, S; Ivanović, A; Jasnić, N; Pavlović, S; Sopta, J; Stojković, M; Todorović, Z; Tosti, T; Đorđević, J; Đurašević, S; Đurović, S1
Beier, K; Kaufmann, P; Krähenbühl, S; März, W; Scharnagl, H; Spaniol, M; Török, M; Wüthrich, J1

Other Studies

2 other study(ies) available for 3-(2,2,2-trimethylhydrazine)propionate and Liver Dysfunction

ArticleYear
The effects of meldonium on the acute ischemia/reperfusion liver injury in rats.
    Scientific reports, 2021, 01-14, Volume: 11, Issue:1

    Topics: Acute Disease; Animals; Gene Expression Regulation; Inflammation; Liver; Liver Diseases; Male; Methylhydrazines; Rats; Rats, Wistar; Reperfusion Injury

2021
Mechanisms of liver steatosis in rats with systemic carnitine deficiency due to treatment with trimethylhydraziniumpropionate.
    Journal of lipid research, 2003, Volume: 44, Issue:1

    Topics: Acyl-CoA Oxidase; Animals; Carnitine; Chemical and Drug Induced Liver Injury; Electron Transport; Ketone Bodies; Lipids; Lipoproteins; Liver; Liver Diseases; Methylhydrazines; Mitochondria, Liver; Oxidation-Reduction; Oxidoreductases; Palmitates; Rats; Rats, Sprague-Dawley

2003